Jedinák Andrej, Maliar Tibor, Grancai Daniel, Nagy Milan
Institute of Molecular Physiology and Genetics, Vlárska 5, Bratislava 835 34, Slovakia.
Phytother Res. 2006 Mar;20(3):214-7. doi: 10.1002/ptr.1836.
Proteases play a key role in a variety of pathologies, including cancer, pancreatitis and thrombosis. Low molecular inhibitors can act as drugs to combat these pathologies. Twelve natural phenolic compounds and one alkaloid were evaluated. Quercetin was used as a standard in the in vitro tests on serine proteases (trypsin, thrombin and urokinase). Salicin showed a highly selective effect with a value of IC50 = 11.4 microm for thrombin, suggesting it may be a suitable lead structure for developing thrombin inhibitors and thus for perspective thrombolytics. Interesting results were also observed for hyperoside with IC50 = 8.3 microm for urokinase. The flavonoid skeleton seems to be a suitable structure for investigating urokinase inhibitors as prospective drugs for cancer therapy. A very high inhibitory activity on trypsin was observed for the flavonoid silybin (IC50 = 3.7 microm), indicating a prospective structure on which to base possible polyphenolic trypsin inhibitors.
蛋白酶在包括癌症、胰腺炎和血栓形成在内的多种病理过程中发挥关键作用。低分子抑制剂可作为对抗这些病理过程的药物。对12种天然酚类化合物和1种生物碱进行了评估。在对丝氨酸蛋白酶(胰蛋白酶、凝血酶和尿激酶)的体外试验中,槲皮素用作标准品。水杨苷对凝血酶表现出高度选择性作用,IC50值为11.4微摩尔,表明它可能是开发凝血酶抑制剂以及未来溶栓剂的合适先导结构。金丝桃苷对尿激酶的IC50值为8.3微摩尔,也观察到了有趣的结果。黄酮类骨架似乎是研究尿激酶抑制剂作为癌症治疗潜在药物的合适结构。黄酮类水飞蓟宾对胰蛋白酶具有非常高的抑制活性(IC50 = 3.7微摩尔),表明它是可能的多酚类胰蛋白酶抑制剂的潜在结构基础。